Benjamin Toll to Administration, Cutaneous
This is a "connection" page, showing publications Benjamin Toll has written about Administration, Cutaneous.
Connection Strength
0.215
-
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend. 2010 Oct 01; 111(3):200-6.
Score: 0.090
-
Validation of a scale for the assessment of food cravings among smokers. Appetite. 2008 Jan; 50(1):25-32.
Score: 0.073
-
Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine Tob Res. 2014 Jul; 16(7):909-14.
Score: 0.030
-
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug Alcohol Depend. 2010 Nov 01; 112(1-2):1-8.
Score: 0.023